Massachusetts Financial Services’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-101,557
Closed -$1.42M 850
2023
Q4
$1.42M Sell
101,557
-3,209
-3% -$44.6K ﹤0.01% 746
2023
Q3
$1.55M Sell
104,766
-4,016
-4% -$56.5K ﹤0.01% 746
2023
Q2
$1.41M Sell
108,782
-2,562
-2% -$29.2K ﹤0.01% 731
2023
Q1
$1.09M Buy
111,344
+91,133
+451% +$973K ﹤0.01% 753
2022
Q4
$215K Sell
20,211
-129,367
-86% -$1.5M ﹤0.01% 839
2022
Q3
$1.56M Buy
+149,578
New +$1.95M ﹤0.01% 749

Other funds holding DVAX

Massachusetts Financial Services's DVAX Position: Q1 2024 in Review

Massachusetts Financial Services sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 101,557 shares — an estimated $1.42M sold.

Massachusetts Financial Services first reported a position in DVAX in Q3 2022 and held it in 6 quarters. The position peaked at $1.56M in Q3 2022. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Massachusetts Financial Services reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 101,557 Dynavax Technologies shares in Q1 2024, an estimated $1.42M.
  • Massachusetts Financial Services first reported a position in Dynavax Technologies in Q3 2022 and held it in 6 quarters.
  • Massachusetts Financial Services's Dynavax Technologies position peaked at $1.56M in Q3 2022.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Massachusetts Financial Services's 13F filing for Q1 2024, filed 14 May 2024.